logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Changchun High-tech: Subsidiary Jinsai Pharmaceutical products included in the new version of medical insurance catalog.

date
07/12/2025
Changchun High-tech Subsidiary Jinsai Pharmaceuticals' related products Jinsai Growth Hormone Injection and Methyldrostanolone Acetate Oral Suspension are included in the new edition of the Basic Medical Insurance Drug List.
Latest
3 m ago
British police: investigating the attack at Heathrow Airport.
3 m ago
Yingda Group: One of the actual controllers of the company and the general manager, Guo Jincai, passed away due to illness.
5 m ago
PICC (601319.SH): Vice President Yu Ze is suspected of serious violations of discipline and laws.
9 m ago
Dongcheng Pharmaceuticals (002675.SZ): Clinical trials of 177Lu-LNC1009 injection have been approved, and currently there are no similar products on the market both domestically and internationally.
12 m ago
Five people were killed in a safety accident at a project construction site in Sanmenxia, Henan.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.